Chemical mapping of anxiety in the brain of healthy humans: An in vivo (1)H‐MRS study on the effects of sex, age, and brain region

por Grachev, Igor D., Apkarian, A. Vania
Publicado no Hum Brain Mapp (2000)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes

por Bajaj, Nin, Hauser, Robert A, Grachev, Igor D
Publicado em 2013

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in s...

por Bajaj, Nin, Hauser, Robert A, Seibyl, John, Kupsch, Andreas, Plotkin, Michail, Chen, Chris, Grachev, Igor D
Publicado no Alzheimers Res Ther (2014)

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials

por O'Brien, John T, Oertel, Wolfgang H, McKeith, Ian G, Grosset, Donald G, Walker, Zuzana, Tatsch, Klaus, Tolosa, Eduardo, Sherwin, Paul F, Grachev, Igor D
Publicado em 2014

Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease

por Cohen, Shani, Waks, Zeev, Elm, Jordan J., Gordon, Mark Forrest, Grachev, Igor D., Navon-Perry, Leehee, Fine, Shai, Grossman, Iris, Papapetropoulos, Spyros, Savola, Juha-Matti
Publicado no BMC Med Inform Decis Mak (2018)

An In Vivo Evaluation of Cerebral Cortical Amyloid with [(18)F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydro...

por Wong, Dean F., Moghekar, Abhay R., Rigamonti, Daniele, Brašić, James R., Rousset, Olivier, Willis, William, Buckley, Chris, Smith, Adrian, Gok, Beril, Sherwin, Paul, Grachev, Igor D.
Publicado em 2013

Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subje...

por Leinonen, Ville, Rinne, Juha O, Wong, Dean F, Wolk, David A, Trojanowski, John Q, Sherwin, Paul F, Smith, Adrian, Heurling, Kerstin, Su, Mandy, Grachev, Igor D
Publicado em 2014

Association between in vivo [(18)F]-flutemetamol amyloid PET imaging and in vivo cerebral cortical histopathology

por Wolk, David A., Grachev, Igor D., Buckley, Chris, Kazi, Hala, Grady, M. Sean, Trojanowski, John Q., Hamilton, Roy H., Sherwin, Paul, McLain, Richard, Arnold, Steven E.
Publicado no Arch Neurol (2011)

Quantification of Motor Function in Huntington Disease Patients Using Wearable Sensor Devices

por Gordon, Mark Forrest, Grachev, Igor D., Mazeh, Itzik, Dolan, Yonatan, Reilmann, Ralf, Loupe, Pippa S., Fine, Shai, Navon-Perry, Leehee, Gross, Nicholas, Papapetropoulos, Spyros, Savola, Juha-Matti, Hayden, Michael R.
Publicado no Digit Biomark (2019)

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects

por Schneider, Frank, Erisson, Lavi, Beygi, Hooman, Bradbury, Margaret, Cohen‐Barak, Orit, Grachev, Igor D., Guzy, Serge, Loupe, Pippa S., Levi, Micha, McDonald, Mirna, Savola, Juha‐Matti, Papapetropoulos, Spyros, Tracewell, William G., Velinova, Maria, Spiegelstein, Ofer
Publicado no Br J Clin Pharmacol (2018)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study

por Grachev, Igor D., Meyer, Philipp M., Becker, Georg A., Bronzel, Marcus, Marsteller, Doug, Pastino, Gina, Voges, Ole, Rabinovich, Laura, Knebel, Helena, Zientek, Franziska, Rullmann, Michael, Sattler, Bernhard, Patt, Marianne, Gerhards, Thilo, Strauss, Maria, Kluge, Andreas, Brust, Peter, Savola, Juha-Matti, Gordon, Mark F., Geva, Michal, Hesse, Swen, Barthel, Henryk, Hayden, Michael R., Sabri, Osama
Publicado no Eur J Nucl Med Mol Imaging (2020)